drugset / Trial / NCT02744378

Comparison of Tacrolimus 0.1% and Clobetasol 0.05% in the Management of Symptomatic Oral Lichen Planus

NCT02744378

Phase 2 Completed 68 enrolled University of Peradeniya
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This clinical study is carried out to assess the efficacy of Tacrolimus and Clobetasol in symptomatic Oral Lichen Planus.

Timeline

Start
2014-06
Primary completion
2015-07
Completion
2015-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Clobetasol Small molecule 0.05 % Topical
Comparator Tacrolimus Small molecule 0.1 % Topical

Indications